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ABSTRACT: Bacterial susceptibility of 40 isolates of Pseudomonas aeruginosa to six antimi-
crobial agents ceftiofur (CFT), colistin (COL), danofloxacin (DNF), enrofloxacin (ENF), gentami-
cin (GEN), and trimethoprim:sulphamethoxazole (TMS) (ratio 1:19) were determined for the
minimal inhibitory concentration (MIC) using the agar-dilution method. All strains were from
ranch-raised mink (Mustela vison) origin, were considered clinically important (mostly with
Pneumonia infection) and were collected during the past fourteen years. The MIC that pre-
vented the growth of 90 % of the bacteria were in µg/ml, 100 for CFT, 100 for COL, 1.57 for DNF
and ENF, 12.5 for GEN and > 100 for TMS. The fluoroquinolones showed higher activity in our
strains than the classical antibiotics used against Pseudomonas aeruginosa. Based on the
MIC values obtained and taking into account the administration form (mixed into the feed or
water supply) of these drugs, we consider that they might be useful for treatment on this
illness.
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SUSCEPTIBILIDAD ANTIMICROBIANA DE Pseudomonas aeruginosa
AISLADAS DE VISONES ENFERMOS
RESUMEN: La susceptibilidad bacteriana de 40 cepas aisladas de Pseudomonas aeruginosa
a seis agentes antimicrobianos ceftiofur (CFT), colistin (COL), danofloxacin (DNF), enrofloxacin
(ENF), gentamicin, (GEN), y trimethoprim:sulphamethoxazole (TMS) (razón 1:19) fue determina-
do para concentración inhibitoria mínima (CIM) usando el mØtodo del agar-dilución. Todas las
cepas fueron aisladas de criaderos de visones (Mustela vison) de casos de neumonía hemorrÆ-
gica y fueron recolectadas durante los œltimos catorce aæos. La CIM que previno el crecimiento
del 90% de las bacterias fue en µg/ml: 100 para CFT, 100 para COL, 1,57 para DNF y ENF,
12,5 para GEN y > 100 para las TMS. Las fluoroquinolonas mostraron actividad mÆs alta en
nuestras de cepas que los clÆsicos antibióticos usados contra Pseudomonas aeruginosa. Ba-
sado en los valores de CIM obtenidos y teniendo en cuenta la forma de administración de
estas drogas (mezcla en el alimento o suministro de agua), consideramos que podrían ser
œtiles para el tratamiento de esta enfermedad.
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MINIMAL INHIBITORY CONCENTRATION (µg/ml) 
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INTRODUCTION
Pseudomonas aeruginosa is known world-
wide to produce severe acute pneumonia in mink
(Mustela vison) and is considered to be an impor-
tant cause of economic loss in fur-bearing ranches.
Hundreds of animals (up to the 80 % of the farm)
may die within 12-24 hours (1, 2, 3, 4, 5). Never-
theless, its antimicrobial sensitivity status in mink
has not been clearly defined.
Many different treatments have been pro-
posed for control of Pseudomonas aeruginosa
(chlorination of the water supply, disinfection with
formalin of mittens and cages, drugs) but the dis-
ease is prevented well only by vaccination with
autogenous formalinized vaccine (5, 6, 7).
Theres no effective therapy for the disease
but it would be possible to alleviate the condition
by prompt and frequent administration of effec-
tive antibiotics.
In this survey, antibiotic susceptibility of 40
strains of Pseudomonas aeruginosa isolated from
fatal pneumonic and septicemic cases in mink has
been conducted.
MATERIAL AND METHODS
Collection of bacterial strains: Forty isolates
of Pseudomonas aeruginosa were obtained from
the Laboratorio de Investigaciones y Diagnóstico
Bacteriológico (LADIB), Universidad Nacional de
La Plata. Mostly of the specimens had been iso-
lated from ranch-raised mink between 4 and 6
months old with sporadic or epizootic pneumonia
infection (n = 31); the rest (n = 9) were from mink
kits (1-4 week-old) with septicaemia (8). The strains
were collected from different ranches (n = 7) of the
southeastern region of the country, between April
1981 and May 1995. They had been stored at -
70”C in trypteine soy broth with 20 % glycerine
and/or lyophilized. All strains were characterized
biochemically, and identification was carried out
according to Lennette et al. (9) and Holt (10) (mainly
with standard methods including serotyping (5)
with a commercial Pseudomonas aeruginosa anti-
sera test (Difco Lab., Detroit USA) following the
manufacturers instructions). Serotypes 1, 4 and
6 were the most commonly found among our
strains (5). Pseudomonas aeruginosa ATCC (Ameri-
can Type Culture Collection) 27853 was used as
reference strain.
Drugs used in this study were: ceftiofur (CFT,
Upjhon Lab., USA), colistin (COL Argentia Lab.,
Argentina), danofloxacin (DNF, Pfizer Lab., Argen-
tina), enrofloxacin (ENF, Bayer Lab., Argentina),
gentamicin (GEN, Sigma Lab., USA), and
trimethoprim: sulphamethoxazole (ratio 1:19)
(TMS, Sigma Lab., USA).
Drug susceptibility testing was carried out
by the agar-dilution method (NCCLS) (11). Each
strain was grown on tripteine soy broth (Britania
Lab., Argentina) at 37”C for 18 h. A broth culture
of each strain was diluted to 106 colony-forming
units/ml and spotted onto Mueller Hinton agar
(Britania Lab., Argentina) supplemented with
Cl2Ca 50 mg/l and Cl2Mg 25 mg/l, containing
serial 2 fold dilutions of each drug by a multiplanter
(Sakuma Seisakusho, Tokyo, Japan). Final con-
centrations of antibiotics tested ranged from 0.05
to 100 µg/ml. The minimal inhibitory concentra-
tion (MIC) was determined after aerobic incuba-
tion at 37°C for 18 h and was considered the low-
est antimicrobial concentration that produced no
visible bacterial growth.
RESULTS
The organisms were highly susceptible to
DNF and ENF for each, (MIC 50: 0.78); (MIC 90:
1.57) (Table 1). COL and GEN showed low values
to MIC 50 but high for MIC 90. The least-effective
drugs were CFT and TMS.
The resistance pattern was homogeneous
among the most recent and oldest isolations (1981-
1995). Moreover, no particular association was
observed between serotyping or case status (sep-
ticaemia, pneumonia epizootics) of the strains and
their antimicrobial susceptibilities.
Table 1. Minimal Inhibitory Concentration (µg/ml)
of 40 strains of Pseudomonas aeruginosa isolated
from 40 mink.
Tabla 1. Concentración inhibitoria mínima (µg/ml) de 40 cepas
de Pseudomonas aeruginosa aisladas de 40 visones.
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DISCUSSION
Literature on susceptibility of Pseudomonas
aeruginosa isolates from mink is scarce. Chemo-
therapy with antibiotics is a commonly-used
method for the control of mink pneumonia. How-
ever, treatment of this illness with these drugs is
not effective owing possibly to its short incubation
period which lasts 18-20 hours and the difficult
to inject hundreds of animals at the same time
during an epizootic (12, 13). Stress of handling
and possible spread of the organism on mink-han-
dling gloves are also possible reasons for poor re-
sults (14). When many mink are to be treated , the
medication should be incorporated in the feed or
water.
In The Netherlands and Denmark, the iso-
lated Pseudomonas aeruginosa strains were highly
resistant to most common antibiotics and chemo-
therapeutic drugs, therefore the disease couldnt
be controlled satisfactorily by medication (4, 6).
Despite the fact that many isolates were re-
ported as being antibiotic-susceptible in vitro, re-
sponse to treatment in field outbreaks was often
ineffective. This was widely documented with sul-
fathiazole, the drug of choice in the past (12, 15,
16, 17), polimixin B and streptomycin (18), sulfa-
diazine-trimethoprim (4) and neomycin and dihy-
drostreptomycin (19).
Moreover, streptomycin and sulfonamides
are not recommended for treating mink because
of their toxicity and adverse local or systemic re-
actions in these animals (20, 21, 22).
Many ranchers rely on sulfathiazole to treat
affected animals despite the fact that some of the
Pseudomonas aeruginosa isolates are not suscep-
tible to sulfathiazole using in vitro disc diffusion
testing methods. Strains of P. aeruginosa virulent
for mink vary in their susceptibility to sulfathiaz-
ole (15).
Long & Gorham (14) reported that most of
the isolates have been susceptible to gentamicin
but resistant to other antibiotics tested; neverthe-
less treatment with gentamicin by injection was
variable and often not satisfactory.
In our study DNF and ENF were active in
vitro against most of the strains suggesting that
these drugs could be appropriate choices for ini-
tial treatment of infections. These 2 drugs have
the additional advantage of oral administration
and the post antibiotic effect (17, 23).
Seven strains were recovered from kits with
general infection. Septicaemia is the most impor-
tant cause of death among kits between 0-4 weeks-
old of our ranches (8).
Two isolates showed values of MIC 100 and
>100 µg/ml for all the drugs used in this survey.
Although studies of multiresistant mechanisms
were not realized, we suspected that this resistant
mechanisms is due to impermeability .
In spite of the use of fluoroquinolones might
be recommended administered in food or water
for prevention and treatment on this illness, the
only way of the correct use of antibiotics is the
isolation of each strain in the outbreak and the
choise of antibiotic of best performance with mi-
nor risk if generation of resistance in this type of
bacteria. Moreover, it this pattern of antimicrobial
susceptibility of Pseudomonas aeruginosa may be
unique to our farms, and further studies from other
countries are needed to determine general recom-
mendations.
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